Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of ($0.31), $0.72 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $39.5 million versus the consensus estimate of $51.7 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.